XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
41.97
+0.17 (0.41%)
At close: May 14, 2026, 4:00 PM EDT
42.00
+0.03 (0.07%)
After-hours: May 14, 2026, 4:10 PM EDT
XOMA Royalty Employees
XOMA Royalty had 14 employees as of December 31, 2025. The number of employees increased by 1 or 7.69% compared to the previous year.
Employees
14
Change (1Y)
1
Growth (1Y)
7.69%
Revenue / Employee
$3,468,214
Profits / Employee
$1,423,714
Market Cap
526.35M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| Rigel Pharmaceuticals | 174 |
| Neurogene | 131 |
| Ocugen | 116 |
| Upstream Bio | 75 |
| Assembly Biosciences | 73 |
| Prothena Corporation | 67 |
| Contineum Therapeutics | 51 |
XOMA News
- 14 days ago - Xoma downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 17 days ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation - PRNewsWire
- 17 days ago - Ligand price target raised to $255 from $230 at Stifel - TheFly
- 17 days ago - Xoma downgraded to Neutral from Buy at Lucid Capital - TheFly
- 17 days ago - Ligand to acquire Xoma for $39.00 per share in cash - TheFly
- 17 days ago - Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand's Position as a Leading Biopharma Royalty Aggregator - GlobeNewsWire
- 17 days ago - Ligand to buy Xoma for $39 per share, WSJ reports - TheFly
- 2 months ago - XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewsWire